{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:02:29Z","timestamp":1784998949736,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10147-026-03070-7","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T17:05:23Z","timestamp":1779815123000},"page":"1619-1627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effectiveness of intra-arterial chemoradiotherapy for advanced maxillary sinus carcinoma: based on the reports of the head and neck cancer registry of Japan"],"prefix":"10.1007","volume":"31","author":[{"given":"Masahiro","family":"Hemmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-4724","authenticated-orcid":false,"given":"Daisuke","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ichi","family":"Nibu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Oridate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"3","key":"3070_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2273.1980.tb01647.x","volume":"5","author":"C Muir","year":"1980","unstructured":"Muir C, Nectoux J (1980) Descriptive epidemiology of malignant neoplasms of nose, nasal cavities, middle-ear and accessory sinuses. Clin Otolaryngol 5(3):195\u2013211. https:\/\/doi.org\/10.1111\/j.1365-2273.1980.tb01647.x","journal-title":"Clin Otolaryngol"},{"issue":"2","key":"3070_CR2","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2009.e36","volume":"1","author":"HS Won","year":"2009","unstructured":"Won HS, Chun SH, Kim BS et al (2009) Treatment outcome of maxillary sinus cancer. Rare Tumors 1(2):e36. https:\/\/doi.org\/10.4081\/rt.2009.e36","journal-title":"Rare Tumors"},{"issue":"2","key":"3070_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.anl.2025.01.007","volume":"52","author":"D Kawakita","year":"2025","unstructured":"Kawakita D, Yoshimoto S, Nakamizo M et al (2025) Head and neck cancer registry of Japan. Auris Nasus Larynx 52(2):122\u2013126. https:\/\/doi.org\/10.1016\/j.anl.2025.01.007","journal-title":"Auris Nasus Larynx"},{"issue":"3","key":"3070_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s13193-020-01062-1","volume":"11","author":"S Bhasker","year":"2020","unstructured":"Bhasker S, Biswas R, Thakar A et al (2020) Treatment outcome and patterns of failure in patients with maxillary sinus cancer: clinical experience from a regional cancer centre in North India. Indian J Surg Oncol 11(3):401\u2013405. https:\/\/doi.org\/10.1007\/s13193-020-01062-1","journal-title":"Indian J Surg Oncol"},{"issue":"2","key":"3070_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.6004\/jnccn.2025.0007","volume":"23","author":"AD Colevas","year":"2025","unstructured":"Colevas AD, Cmelak AJ, Pfister DG et al (2025) NCCN Guidelines\u00ae insights: head and neck cancers, version 2.2025. J Natl Compr Canc Netw 23(2):2\u201311. https:\/\/doi.org\/10.6004\/jnccn.2025.0007","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"3070_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0196-0709(95)90041-1","volume":"16","author":"I Alvarez","year":"1995","unstructured":"Alvarez I, Suarez C, Rodrigo J et al (1995) Prognostic factors in paranasal sinus cancer. Am J Otolaryngol 16(2):109\u2013114. https:\/\/doi.org\/10.1016\/0196-0709(95)90041-1","journal-title":"Am J Otolaryngol"},{"issue":"9","key":"3070_CR7","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ijom.2021.12.006","volume":"51","author":"J Heianna","year":"2022","unstructured":"Heianna J, Makino W, Hirakawa H et al (2022) Therapeutic efficacy of intra-arterial docetaxel and nedaplatin infusion concomitant with radiotherapy for T4 maxillary sinus squamous cell carcinoma. Int J Oral Maxillofac Surg 51(9):1123\u20131130. https:\/\/doi.org\/10.1016\/j.ijom.2021.12.006","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"7","key":"3070_CR8","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.joms.2011.06.221","volume":"70","author":"J Kang","year":"2012","unstructured":"Kang J, Cho S, Kim J et al (2012) Treatment outcomes between concurrent chemoradiotherapy and combination of surgery, radiotherapy, and\/or chemotherapy in stage III and IV maxillary sinus cancer: multi-institutional retrospective analysis. J Oral Maxillofac Surg 70(7):1717\u20131723. https:\/\/doi.org\/10.1016\/j.joms.2011.06.221","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"3070_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0002-9610(05)80089-3","volume":"168","author":"K Robbins","year":"1994","unstructured":"Robbins K, Vicario D, Seagren S et al (1994) A targeted supradose Cisplatin chemoradiation protocol for advanced head and neck-cancer. Am J Surg 168(5):419\u2013422. https:\/\/doi.org\/10.1016\/S0002-9610(05)80089-3","journal-title":"Am J Surg"},{"issue":"9","key":"3070_CR10","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/cncr.24916","volume":"116","author":"C Rasch","year":"2010","unstructured":"Rasch C, Hauptmann M, Schornagel J et al (2010) Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 116(9):2159\u20132165. https:\/\/doi.org\/10.1002\/cncr.24916","journal-title":"Cancer"},{"issue":"986","key":"3070_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1259\/bjr\/16954991","volume":"83","author":"N Kashiwagi","year":"2010","unstructured":"Kashiwagi N, Nakanishi K, Kozuka T et al (2010) Vascular supply with angio-CT for superselective intra-arterial chemotherapy in advanced maxillary sinus cancer. Br J Radiol 83(986):171\u2013178. https:\/\/doi.org\/10.1259\/bjr\/16954991","journal-title":"Br J Radiol"},{"issue":"12","key":"3070_CR12","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.jcms.2017.10.003","volume":"45","author":"T Ono","year":"2017","unstructured":"Ono T, Tanaka N, Umeno H et al (2017) Treatment outcomes of locally advanced squamous cell carcinoma of the maxillary sinus treated with chemoradioselection using superselective intra-arterial cisplatin and concomitant radiation: implications for prognostic factors. J Craniomaxillofac Surg 45(12):2128\u20132134. https:\/\/doi.org\/10.1016\/j.jcms.2017.10.003","journal-title":"J Craniomaxillofac Surg"},{"issue":"6","key":"3070_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.otohns.2006.12.018","volume":"136","author":"K Shiga","year":"2007","unstructured":"Shiga K, Yokoyama J, Hashimoto S et al (2007) Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma. Otolaryngol Head Neck Surg 136(6):1003\u20131009. https:\/\/doi.org\/10.1016\/j.otohns.2006.12.018","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"12","key":"3070_CR14","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1038\/bjc.2013.663","volume":"109","author":"A Homma","year":"2013","unstructured":"Homma A, Sakashita T, Yoshida D et al (2013) Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer 109(12):2980\u20132986. https:\/\/doi.org\/10.1038\/bjc.2013.663","journal-title":"Br J Cancer"},{"issue":"20","key":"3070_CR15","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1002\/cncr.24515","volume":"115","author":"A Homma","year":"2009","unstructured":"Homma A, Oridate N, Suzuki F et al (2009) Superselective high-dose Cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses a single institution experience. Cancer 115(20):4705\u20134714. https:\/\/doi.org\/10.1002\/cncr.24515","journal-title":"Cancer"},{"issue":"3","key":"3070_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10147-025-02702-8","volume":"30","author":"H Shinomiya","year":"2025","unstructured":"Shinomiya H, Matsuura K, Onimaru R et al (2025) Dose-finding and efficacy confirmation trial of the superselective intra-arterial infusion of Cisplatin and concomitant radiation therapy for locally advanced maxillary sinus cancer (JCOG1212): final analysis. Int J Clin Oncol 30(3):489\u2013496. https:\/\/doi.org\/10.1007\/s10147-025-02702-8","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"3070_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.anl.2025.09.004","volume":"52","author":"N Hanai","year":"2025","unstructured":"Hanai N, Ando M, Ishiki H et al (2025) Summary of Japanese clinical practice guidelines for head and neck cancer\u20142025 update edited by the Japan Society for Head and Neck Cancer. Auris Nasus Larynx 52(6):709\u2013724. https:\/\/doi.org\/10.1016\/j.anl.2025.09.004","journal-title":"Auris Nasus Larynx"},{"issue":"3","key":"3070_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.22575\/interventionalradiology.2022-0042","volume":"9","author":"D Yoshida","year":"2024","unstructured":"Yoshida D (2024) Intra-arterial chemotherapy for head and neck cancer. Interv Radiol 9(3):127\u2013133. https:\/\/doi.org\/10.22575\/interventionalradiology.2022-0042","journal-title":"Interv Radiol"},{"issue":"3","key":"3070_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1159\/000332759","volume":"4","author":"T Nakashima","year":"2011","unstructured":"Nakashima T, Yasumatsu R, Toh S et al (2011) Advanced maxillary sinus cancer treated with concurrent chemoradiotherapy with intra-arterial Cisplatin\/docetaxel and oral S-1: own experience and literature review. Case Rep Oncol 4(3):492\u2013498. https:\/\/doi.org\/10.1159\/000332759","journal-title":"Case Rep Oncol"},{"key":"3070_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2393","author":"J Sterne","year":"2009","unstructured":"Sterne J, White I, Carlin J et al (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ-Br Med J. https:\/\/doi.org\/10.1136\/bmj.b2393","journal-title":"BMJ-Br Med J"},{"issue":"7","key":"3070_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/sim.5984","volume":"33","author":"PC Austin","year":"2014","unstructured":"Austin PC (2014) The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med 33(7):1242\u20131258. https:\/\/doi.org\/10.1002\/sim.5984","journal-title":"Stat Med"},{"issue":"11","key":"3070_CR22","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.1245\/s10434-023-13934-1","volume":"30","author":"K Eguchi","year":"2023","unstructured":"Eguchi K, Omura G, Murakami N et al (2023) Comparison of survival outcomes between larynx-preserving open partial pharyngectomy and radiotherapy or chemoradiotherapy in patients with hypopharyngeal squamous cell carcinoma: a single-center retrospective analysis with inverse probability of treatment weighting adjustments. Ann Surg Oncol 30(11):6867\u20136874. https:\/\/doi.org\/10.1245\/s10434-023-13934-1","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3070_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","volume":"75","author":"S Cole","year":"2004","unstructured":"Cole S, Hern\u00e1n M (2004) Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 75(1):45\u201349. https:\/\/doi.org\/10.1016\/j.cmpb.2003.10.004","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"3070_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/jrr\/rraa120","volume":"62","author":"T Abe","year":"2021","unstructured":"Abe T, Saito S, Iino M et al (2021) Results of definitive radiotherapy with concurrent chemotherapy for maxillary sinus carcinomas with neck lymph node metastasis. J Radiat Res 62(1):104\u2013109. https:\/\/doi.org\/10.1093\/jrr\/rraa120","journal-title":"J Radiat Res"},{"issue":"5","key":"3070_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.anl.2008.11.002","volume":"36","author":"G Nishimura","year":"2009","unstructured":"Nishimura G, Tsukuda M, Mikami Y et al (2009) The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients. Auris Nasus Larynx 36(5):547\u2013554. https:\/\/doi.org\/10.1016\/j.anl.2008.11.002","journal-title":"Auris Nasus Larynx"},{"issue":"4","key":"3070_CR26","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/hed.23639","volume":"37","author":"T Sakashita","year":"2015","unstructured":"Sakashita T, Hayashi R, Homma A et al (2015) Multi-institutional retrospective study for the evaluation of ocular function-preservation rates in maxillary sinus squamous cell carcinomas with orbital invasion. Head Neck 37(4):537\u2013542. https:\/\/doi.org\/10.1002\/hed.23639","journal-title":"Head Neck"},{"issue":"2","key":"3070_CR27","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00405-021-06822-5","volume":"279","author":"N Tsushima","year":"2022","unstructured":"Tsushima N, Kano S, Suzuki T et al (2022) Salvage surgery improves the treatment outcome of patients with residual\/recurrent maxillary sinus cancer after superselective intra-arterial cisplatin infusion with concomitant radiation therapy. Eur Arch Otorhinolaryngol 279(2):899\u2013905. https:\/\/doi.org\/10.1007\/s00405-021-06822-5","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"3070_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bjoms.2014.01.018","volume":"52","author":"T Sakashita","year":"2014","unstructured":"Sakashita T, Homma A, Hatakeyama H et al (2014) Salvage operations for patients with persistent or recurrent cancer of the maxillary sinus after superselective intra-arterial infusion of cisplatin with concurrent radiotherapy. Br J Oral Maxillofac Surg 52(4):323\u2013328. https:\/\/doi.org\/10.1016\/j.bjoms.2014.01.018","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"6","key":"3070_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1093\/jjco\/hyq009","volume":"40","author":"N Jang","year":"2010","unstructured":"Jang N, Wu H, Park C et al (2010) Definitive radiotherapy with or without chemotherapy for T3\u20134N0 squamous cell carcinoma of the maxillary sinus and nasal cavity. Jpn J Clin Oncol 40(6):542\u2013548. https:\/\/doi.org\/10.1093\/jjco\/hyq009","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"3070_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/hed.23030","volume":"35","author":"H Nishino","year":"2013","unstructured":"Nishino H, Takanosawa M, Kawada K et al (2013) Multidisciplinary therapy consisting of minimally invasive resection, irradiation, and intra-arterial infusion of 5-fluorouracil for maxillary sinus carcinomas. Head Neck 35(6):772\u2013778. https:\/\/doi.org\/10.1002\/hed.23030","journal-title":"Head Neck"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-026-03070-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-026-03070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T16:35:40Z","timestamp":1784997340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-026-03070-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3070"],"URL":"https:\/\/doi.org\/10.1007\/s10147-026-03070-7","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data collection was approved by the Cancer Registry Board of the JSHNC (No. 2024-01). This study was approved by the Institutional Review Board of Yokohama City University (F250200003).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for obtaining informed consent was waived by the ethics committee because this retrospective observational study used anonymized secondary data.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}